EcoDrugPlus

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSDORG00000007418
Gene Symbol: DPYD
4 Cross references
225 Possible Orthologues:

Dipeptidyl Peptidase 4

Ensembl ID : ENSDORG00000001896
Gene Symbol: DPP4
3 Cross references
286 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSDORG00000004970
Gene Symbol: DDR2
4 Cross references
264 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSDORG00000024953
Gene Symbol: DRD1
4 Cross references
262 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSDORG00000013516
Gene Symbol: DRD2
4 Cross references
222 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSDORG00000012995
Gene Symbol: DRD3
4 Cross references
209 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSDORG00000004554
Gene Symbol: DRD5
4 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSDORG00000004750
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSDORG00000006651
Gene Symbol: EGLN1
2 Cross references
239 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSDORG00000025780
Gene Symbol: EGLN2
2 Cross references
199 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSDORG00000014235
Gene Symbol: EGLN3
1 Cross references
208 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSDORG00000003635
Gene Symbol: EPAS1
4 Cross references
225 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).